Cutaneous endometriosis
Cutaneous endometriosis ยท scar endometrioma ยท umbilical endometriosis (Villar nodule)
Cutaneous endometriosis is the presence of functional endometrial glands and stroma within the skin โ most commonly in caesarean / abdominal-surgery scars (scar endometrioma), but also in the umbilicus (Villar nodule) without prior surgery. It accounts for <1% of all endometriosis. Cyclical pain and swelling synchronous with menses is pathognomonic. The principal skin-oncology relevance is as a differential for Sister Mary Joseph nodule (umbilical metastasis) and cutaneous metastatic disease.
Classification
- Scar endometriosis (commonest cutaneous variant):
- Caesarean-section scar (over 70%).
- Episiotomy / perineal scar.
- Laparoscopic / laparotomy port-site scar.
- Implantation occurs intra-operatively from uterine tissue spillage.
- Primary cutaneous endometriosis (no prior surgery):
- Umbilical (Villar nodule): spontaneous; classical extra-pelvic site.
- Inguinal / vulval.
- Rare other sites: trunk, limbs.
- ~0.5-1% of all endometriosis cases.
Clinical features
- Firm subcutaneous nodule.
- Bluish or red-brown discolouration; sometimes haemorrhagic.
- Tender, particularly:
- Cyclical pain / swelling synchronous with menses (pathognomonic).
- Sometimes bleeding / serosanguineous discharge during menstruation.
- Size: usually <3 cm but can be larger; slowly enlarging.
- Pre-menopausal women; ages 20-40 typically.
- Concurrent pelvic endometriosis in 25-50%.
Differentials
- Sister Mary Joseph nodule โ umbilical metastasis from internal malignancy (gastric, ovarian, colon, pancreatic) โ most important DDx; biopsy if doubt.
- Cutaneous metastasis.
- Epidermoid cyst โ non-cyclical; central punctum.
- Keloid scar.
- Suture granuloma.
- Stitch / scar abscess.
- Incisional hernia with omental fat.
- Desmoid tumour (FAP / sporadic; abdominal-wall).
- Granuloma, foreign-body reaction.
Investigations
- Detailed history: cyclicity, prior surgery, gynaecological symptoms.
- USS: heterogeneous solid mass; well-defined margins.
- MRI: T1-hyperintense (haemorrhagic foci); useful for extent.
- Skin biopsy / excisional biopsy: definitive diagnosis.
- Histology: endometrial glands + stroma; haemosiderin; hormonal-cycle changes; CD10+ stroma (endometrial-stroma IHC marker).
- If umbilical with no prior surgery, exclude internal malignancy:
- CT abdomen / pelvis.
- Tumour markers (CA125, CEA, CA19-9).
- Gastroscopy / colonoscopy if clinical features.
- Pelvic USS / MRI to screen for concurrent pelvic endometriosis.
- Gynaecology referral.
Management
- Surgical excision: complete local excision with 1 cm margins is curative; specimen for definitive pathology.
- Recurrence ~5-10%; multidisciplinary planning if recurrent / extensive (cover mesh in fascial-defect surgery).
- Medical: hormonal therapy for residual / pelvic disease โ combined OCP, progestins, GnRH analogues, danazol (BMI considerations), aromatase inhibitors.
- Long-term: multidisciplinary (plastic surgery, gynaecology, dermatology).
- Counsel:
- Benign nature; symptom relief excellent with excision.
- Hormonal therapy not always required after excision unless pelvic disease.
- Pregnancy: lesions may regress; fertility-related plans.
- Sister Mary Joseph exclusion mandatory in umbilical disease.
References
- Steck WD, Helwig EB. Cutaneous endometriosis. JAMA. 1965;191:167-170.
- Friedman PM, Rico MJ. Cutaneous endometriosis. Dermatol Online J. 2000;6:8.
- Khamechian T et al. Cutaneous endometriosis: a case series and literature review. Int J Womens Dermatol. 2020;6:226-229.
- Dunselman GAJ et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-412.
- NICE NG73. Endometriosis: diagnosis and management. London: NICE; 2017 (last updated 11 November 2024; reviewed 2 September 2025).
Spot a correction?
If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.

